Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cathflo Activase (Alteplase) Pediatric Study (CAPS)

NCT00307580 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00307580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00307580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cathflo Activase (Alteplase) Pediatric Study (CAPS)
Lead sponsor
Genentech, Inc.
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2002
Completion date
May 31, 2003
Enrollment
300
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dysfunctional central venous access devices (cvads)